Literature DB >> 25276270

Multiorgan Streptococcus milleri Abscesses During FOLFIRINOX Chemotherapy in a Patient With Metastatic Pancreatic Cancer.

Evelyn Brosnan1, Kabir Mody2, Richard A Zuckerman3, Kathryn L Ruoff4, J Marc Pipas2.   

Abstract

Entities:  

Year:  2014        PMID： 25276270      PMCID： PMC4171978     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  10 in total

Review 1.  Streptococcus milleri group: renewed interest in an elusive pathogen.

Authors:  S C Piscitelli; J Shwed; P Schreckenberger; L H Danziger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

2.  Oral bacterial cultures in nontraumatic brain abscesses: results of a first-line study.

Authors:  Andreas Albert Mueller; Belma Saldamli; Stefan Stübinger; Clemens Walter; Ursüla Flückiger; Adrian Merlo; Katja Schwenzer-Zimmerer; Hans-Florian Zeilhofer; Stephan Zimmerer
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2009-01-04

3.  Irinotecan plus oxaliplatin and leucovorin-modulated fluorouracil in advanced pancreatic cancer--a Groupe Tumeurs Digestives of the Federation Nationale des Centres de Lutte Contre le Cancer study.

Authors:  Thierry Conroy; Bernard Paillot; Eric François; Roland Bugat; Jacques-Henri Jacob; Ulrich Stein; Salvador Nasca; Jean-Philippe Metges; Olivier Rixe; Pierre Michel; Emmanuelle Magherini; Aliette Hua; Gael Deplanque
Journal:  J Clin Oncol       Date:  2005-02-20       Impact factor: 44.544

4.  Lung abscesses in 2 patients with Lancefield group F streptococci (Streptococcus milleri group).

Authors:  Vijaya K Gogineni; Ariel Modrykamien
Journal:  Respir Care       Date:  2011-06-17       Impact factor: 2.258

5.  FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.

Authors:  Thierry Conroy; Françoise Desseigne; Marc Ychou; Olivier Bouché; Rosine Guimbaud; Yves Bécouarn; Antoine Adenis; Jean-Luc Raoul; Sophie Gourgou-Bourgade; Christelle de la Fouchardière; Jaafar Bennouna; Jean-Baptiste Bachet; Faiza Khemissa-Akouz; Denis Péré-Vergé; Catherine Delbaldo; Eric Assenat; Bruno Chauffert; Pierre Michel; Christine Montoto-Grillot; Michel Ducreux
Journal:  N Engl J Med       Date:  2011-05-12       Impact factor: 91.245

6.  Concomitant occurrence of pulmonary invasive aspergillosis and Pneumocystis pneumonia during FOLFIRINOX chemotherapy for pancreatic carcinoma.

Authors:  Julien Péron; Olfa Derbel; Anne-Sophie Penet; Mattia Stella; Pierre Méeus; Florence Orlandini; Maurice Pérol; Christelle de la Fouchardière
Journal:  Pancreas       Date:  2013-01       Impact factor: 3.327

Review 7.  Streptococcus anginosus ("Streptococcus milleri"): the unrecognized pathogen.

Authors:  K L Ruoff
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

8.  5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinoma.

Authors:  Elias Assaf; Muriel Verlinde-Carvalho; Catherine Delbaldo; Julien Grenier; Zineb Sellam; Damien Pouessel; Linda Bouaita; Isabelle Baumgaertner; Iradj Sobhani; Claude Tayar; Muriel Paul; Stéphane Culine
Journal:  Oncology       Date:  2011-07-18       Impact factor: 2.935

9.  Brain abscess due to Streptococcus MG-intermedius (Streptococcus milleri).

Authors:  J C Melo; M J Raff
Journal:  J Clin Microbiol       Date:  1978-06       Impact factor: 5.948

10.  Is there any difference in pyogenic liver abscess caused by Streptococcus milleri and Klebsiella spp?: retrospective analysis over a 10-year period in a regional hospital.

Authors:  Siu-Tong Law; Michael Kin Kong Li
Journal:  J Microbiol Immunol Infect       Date:  2012-05-10       Impact factor: 4.399
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.